LIT

Description

LIT, Leibniz Institute for Immunotherapy, develops immune-cell therapies using synthetic and pharmacological reprogramming, spanning basic immune research, preclinical therapeutic development, and early clinical trials for cancer, autoimmunity, and chronic inflammation.

Related

• APC Microbiome IrelandAPC Microbiome Ireland studies gastrointestinal bacterial communities and uses microbiome-based science to address human health, chronic…
• Area Science ParkArea Science Park is a public research organisation supporting technological innovation, research-to-market transfer, and deep tech startup…
• Association Santakos slėnis (Santaka Valley)Association Santakos slėnis (Santaka Valley) builds an integrated science, study and business centre that supports public and private…
• Athens LifeTech ParkAthens LifeTech Park provides laboratory infrastructure and specialised life-sciences R&D services, supporting bioanalysis,…
• BBI CambridgeBBI Cambridge develops life sciences executives through academic expertise, collaborations with companies, universities, and technology…
• Belgian Nuclear Research CentreBelgian Nuclear Research Centre conducts nuclear science research and develops applications including radiopharmaceuticals, reactor…
• Bernhard-Nocht-Institut für TropenmedizinBernhard-Nocht-Institut für Tropenmedizin conducts research, teaching and clinical work on tropical and emerging infectious diseases,…
• Biocenter FinlandBiocenter Finland provides open‑access technology platforms and services that enable life‑science and biomedical research, supplying…
• BiocevBiocev conducts functional genomics, cell biology, virology, protein engineering, biomaterials, tissue engineering, and diagnostic and…